You are here

Article Text

Article menu
Download PDFPDF
Community and primary care nursing
Healthcare providers need to address misconceptions young women have around IUDs and their fertility
  1. Elise D Berlan
  1. Department of Pediatrics, Nationwide Children’s Hospital and The Ohio State University College of Medicine, Columbus, Ohio, USA
  1. Correspondence to Dr Elise D Berlan, Nationwide Children’s Hospital, The Ohio State University College of Medicine, Livingston Ambulatory Center, Columbus, OH 43215, USA; elise.berlan{at}nationwidechildrens.org

https://doi.org/10.1136/eb-2016-102516

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Payne JB, Sundstrom B, DeMaria AL, et al. A qualitative study of young women’s beliefs about intrauterine devices: fear of infertility. J Midwifery Womens Health 2016;61:482–8.

    Implications for practice and research

    • Healthcare providers should be aware that adolescent and young adult women may receive few positive messages about intrauterine device (IUD) use from their family and friends, and lean heavily on their healthcare provider for information about IUDs.

    • When counselling adolescents and young adults about contraceptive options, healthcare providers should communicate the safety of IUDs, reversibility of the method, and that menstrual changes after IUD placement are expected and do not threaten future fertility.

    Context

    Most pregnancies among adolescent and unmarried young women in the USA are unintended. Intrauterine devices (IUDs) are safe and highly effective contraceptives, and recommended as first-line options for women, including adolescents.1 Although IUD use among American women has been increasing over the last …

    View Full Text

    Footnotes

    • Competing interests EB receives honoraria from Merck & Co for being a Nexplanon trainer.

    • Provenance and peer review Commissioned; internally peer reviewed.